The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a ...
The US. Food and Drug Administration (FDA) has officially cleared Deseyne contact lenses, developed by Bruno Vision Care, for ...
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that ...
NEW YORK--(BUSINESS WIRE)-- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced ...
A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
In recent articles, I have argued for an approach to presbyopia correction that selects a presbyopic IOL according to each patient’s unique presbyopia profile. In my experience, this customized ...
Cataltheia Group’s Bruno Vision Care secures FDA clearance for Deseyne, the first EDOF contact lens for presbyopia.
NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its ...
SAN DIEGO — An experimental combination of drugs can temporarily correct the vision of people with presbyopia, a new study shows. "With one drop in the morning, you don't need glasses all day," said ...
The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. Pilocarpine HCl ophthalmic solution 1.25% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback